Related Experiment Videos
Cognitive function in Parkinson's disease: in relation to motor symptoms
Y Iwasaki1, M Kinoshita, K Ikeda
1Fourth Department of Medicine, Toho University Ohashi Hospital, Japan.
The International Journal of Neuroscience
|August 1, 1989
Summary
Parkinson's disease (PD) patients show deficits in cognitive functions like memory and visuospatial skills. These neuropsychological test results correlate with motor symptoms, suggesting dopaminergic pathway involvement in PD diagnosis.
Area of Science:
- Neuroscience
- Neurology
- Psychology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting motor function.
- Cognitive impairments are increasingly recognized as a significant non-motor symptom in PD.
- The utility of neuropsychological testing for diagnosing PD and understanding its cognitive impact requires further investigation.
Purpose of the Study:
- To evaluate the performance of Parkinson's disease patients on specific neuropsychological tests.
- To determine the applicability of these tests for aiding in the diagnosis of Parkinson's disease.
- To explore the relationship between motor symptoms and cognitive deficits in PD.
Main Methods:
- A battery of tests assessing motor and intellectual functions was administered.
- Thirty-six patients diagnosed with Parkinson's disease participated.
- Twenty age- and education-matched healthy individuals served as controls.
Main Results:
- Patients with Parkinson's disease scored significantly lower on all administered neuropsychological tests compared to controls.
- A significant negative correlation was observed between bradykinesia and visuospatial test performance.
- Rigidity in PD patients showed a significant negative correlation with memory test scores.
Conclusions:
- Neuropsychological tests reveal significant cognitive deficits in Parkinson's disease patients.
- Specific motor symptoms, such as bradykinesia and rigidity, are associated with particular cognitive impairments.
- Findings support the role of dopaminergic pathway dysfunction in the observed motor and cognitive deficits in Parkinson's disease.